Neurodegeneration, oxidative stress and lipid metabolism plasma biomarkers to differentiate Parkinson's disease from atypical parkinsonian syndromes.
Fiche publication
Date publication
juin 2023
Journal
Revue neurologique
Auteurs
Membres identifiés du Cancéropôle Est :
Dr LIZARD Gérard, Dr PAIS DE BARROS Jean-Paul
Tous les auteurs :
Schneider V, Vejux A, Nury T, Dupont G, Pais de Barros JP, Lakomy D, Lizard G, Moreau T
Lien Pubmed
Résumé
The identification of blood biomarkers appears to be a means of improving diagnosis accuracy in Parkinson's disease (PD) and atypical parkinsonian syndromes (APS). We, therefore, evaluate the performance of neurodegeneration, oxidative stress and lipid metabolism plasma biomarkers to distinguish PD from APS.
Mots clés
Atypical parkinsonian syndromes, Lipid metabolism, Neurodegeneration, Oxidative stress, Parkinson's disease, Plasma biomarkers
Référence
Rev Neurol (Paris). 2023 06 14;: